SG

Seema Gupta

Active Director Director DIN 01075775
DIN 01075775 First appointment Apr 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2002
Shareholding value •••• Premium profile

About Seema Gupta

Data last updated:

Seema Gupta is a Director at Aegis Elixirs Limited (since 2002). The company operates in Pharma. Aegis Elixirs Limited reported revenue of ₹1.1 Lakh (FY 2024).

DIN 01075775
Primary Designation Director
Industry Pharma
First Appointment 16 Apr 2002
Oldest Company Age 24 yrs
Largest company Aegis Elixirs Limited · ₹1.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aegis Elixirs Limited U24232PB2002PLC025077
Director16 Apr 20022002₹1.1 Lakh (FY 2024)Active

Board colleagues of Seema Gupta

NameDINCompanyDesignation
Ajay Gupta01098230Aegis Elixirs LimitedDirector
Sachin Gupta01098246Aegis Elixirs LimitedDirector

Directorship timeline

Open interactive timeline →
Aegis Elixirs Limited
Premium access

Shareholding and investment profile for Seema Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Gupta

Seema Gupta currently holds 1 directorship: Aegis Elixirs Limited (Director, since 16 Apr 2002, revenue ₹1.1 Lakh (FY 2024)).

Seema Gupta was first appointed on 16 Apr 2002 as Director at Aegis Elixirs Limited.

The current boards of Seema Gupta's companies include Ajay Gupta (Aegis Elixirs Limited), Sachin Gupta (Aegis Elixirs Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available